News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
TDxd for treating HER2-positive breast cancer with brain and/or leptomeningeal metastases
Aug 17, 2024, 14:04

TDxd for treating HER2-positive breast cancer with brain and/or leptomeningeal metastases

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X about recent paper by Takahiro Nakayama et al., titled “Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)” published on Breast Cancer.

Authors: Takahiro Nakayama, Naoki Niikura, Takashi Yamanaka, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Hironori Nomura, Shosuke Kita, Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, Shuji Sakai, Daisuke Takiguchi, Takehiko Takata, Armin Bastanfard, Kazuhito Shiosakai, Junji Tsurutani

Image

“ Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) | Breast Cancer.”

Source: Elisabetta Bonzano/X

Akihiko Shimomura Armin Bastanfard Breast Cancer cancer Daisuke Takiguchi Elisabetta Bonzano HER2 positive breast cancer Hironori Nomura IRCCS San Matteo Polyclinic Foundation Junji Tsurutani Kazuhito Shiosakai Kazuo Matsuura Kenichi Inoue leptomeningeal metastases Miki Yamaguchi Mitsugu Yamamoto Naoki Niikura Nobuhiro Shibata OncoDaily Oncology Sachiko Takahara Shosuke Kita Shuji Sakai Takahiro Nakayama Takashi Yamanaka Takehiko Takata Tomoyuki Aruga Trastuzumab deruxtecan Yuri Ozaki
Special Coverage
Opinion
Nov 13, 2024, 17:14
Share your experiences of life with a kidney cancer diagnosis - Action Kidney Cancer
Blog
Nov 13, 2024, 16:51
The 11th edition of Richi Entrepreneurs has officially kicked off
Blog
Nov 13, 2024, 16:49
Dégi László Csaba: Transforming Cancer Care Together
Blog
Nov 13, 2024, 16:45
Jun Gong: The best awards are patient awards
Blog
Nov 13, 2024, 16:39
Bami Adenipekun: How being impacted by breast cancer for over 3 decades shapes the work that I do
Insight
Nov 13, 2024, 16:25
A clear picture of the ground reality
Insight
Nov 13, 2024, 16:23
Make your mark in Oncology research with JCO Oncology Advances - ASCO
Blog
Nov 13, 2024, 16:08
Evolving role of Radiation in early stage NSCLC by Dr. Annalisa Nardone
Insight
Nov 13, 2024, 16:02
Exploring New Avenues in Breast Cancer Treatment - The Babak Lab
Insight
Nov 13, 2024, 16:00
Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases
Blog
Nov 13, 2024, 15:56
Awareness campaigns have helped Increase Lung Cancer Screening Rates - IASLC
Blog
Nov 13, 2024, 15:56
Jennifer Ivanovich: Thrilled to see the announcement of the new ESMO Rare Cancers journal